Since diabetes mellitus is a major cause of morbidity and mortality in the United States largely due to the association of coronary artery disease, we propose to test the following hypotheses regarding mechanisms of microvascular control during metabolic stress and ischemia in diabetes. Our first goal is to determine the mechanism of impaired coronary vasodilation in diabetic and acutely hyperglycemic dogs to graded reductions in perfusion pressure. To achieve this goal, three subaims will be evaluated: a) determine the segmental microvascular vasodilator reserve in diabetic and hyperglycemic dogs following coronary stenoses; b) determine the role of enhanced endoperoxide production distal to coronary stenoses in diabetes and hyperglycemia; and c) determine the role of oxygen-derived free radicals distal to a coronary stenoses in diabetes and hyperglycemia. The second major goal of these studies is to test the hypotheses that coronary vasodilation to increased metabolic demand is impaired in diabetic and acutely hyperglycemic animals. To further our understanding in this area we will evaluate the role of arginine-derived nitric oxide in ATP-sensitive potassium channels in normal, diabetic and hyperglycemic dogs. We will also evaluate the role of enhanced endoperoxide production and/or free radical generation in mediating this response. The third major goal of this experiment is to test the clinically relevant hypothesis that the class of drug therapy (insulin versus glibenclamide) will differentially affect the coronary microvascular response to ischemia in diabetic dogs. To test these hypotheses three groups of dogs will be studied: normal euglycemic dogs, alloxan-induced diabetic dogs and acutely hyperglycemic dogs. For the first two major goals euglycemic, alloxan-induced diabetic dogs (l week) and acute hyperglycemic dogs will be studied. For the third major goal, dogs with alloxan-induced diabetes of three months duration will be used. Hemodynamics, coronary perfusion pressure and myocardial perfusion will be measured during all experiments. Epicardial coronary microvascular diameters will be measured in the in vivo intact beating left ventricle preparation using jet ventilation timed to the cardiac cycle and stroboscopic epi-illumination coupled with intravital microscopy. We anticipate that these studies will identify mechanisms responsible for the increased cardiovascular morbidity and mortality in diabetic patients.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL051308-04
Application #
2430726
Study Section
Cardiovascular and Renal Study Section (CVB)
Project Start
1994-07-08
Project End
1999-05-31
Budget Start
1997-06-01
Budget End
1999-05-31
Support Year
4
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of Iowa
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
041294109
City
Iowa City
State
IA
Country
United States
Zip Code
52242
Ammar Jr, R F; Gutterman, D D; Brooks, L A et al. (2000) Impaired dilation of coronary arterioles during increases in myocardial O(2) consumption with hyperglycemia. Am J Physiol Endocrinol Metab 279:E868-74
Oltman, C L; Kane, N L; Gutterman, D D et al. (2000) Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size. Am J Physiol Endocrinol Metab 279:E176-81
Ammar Jr, R F; Gutterman, D D; Brooks, L A et al. (2000) Free radicals mediate endothelial dysfunction of coronary arterioles in diabetes. Cardiovasc Res 47:595-601
Widmann, M D; Weintraub, N L; Fudge, J L et al. (1998) Cytochrome P-450 pathway in acetylcholine-induced canine coronary microvascular vasodilation in vivo. Am J Physiol 274:H283-9
Miller Jr, F J; Dellsperger, K C; Gutterman, D D (1998) Pharmacologic activation of the human coronary microcirculation in vitro: endothelium-dependent dilation and differential responses to acetylcholine. Cardiovasc Res 38:744-50
Oltman, C L; Weintraub, N L; VanRollins, M et al. (1998) Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation. Circ Res 83:932-9
Oltman, C L; Gutterman, D D; Scott, E C et al. (1997) Effects of glycosylated hemoglobin on vascular responses in vitro. Cardiovasc Res 34:179-84
Embrey, R P; Brooks, L A; Dellsperger, K C (1997) Mechanism of coronary microvascular responses to metabolic stimulation. Cardiovasc Res 35:148-57
Miller Jr, F J; Dellsperger, K C; Gutterman, D D (1997) Myogenic constriction of human coronary arterioles. Am J Physiol 273:H257-64
Dellsperger, K C (1996) Potassium channels and the coronary circulation. Clin Exp Pharmacol Physiol 23:1096-101

Showing the most recent 10 out of 11 publications